Table 3.
Opioid overdose-risk behaviors as a function of time.
| Baseline | Month 12 | Statistical Test from Pre-Post Regression | |
|---|---|---|---|
| Escalating Opioid Dosage, n, % | 38 (86.4 %) | 7 (15.9 %) | X2(1) = 47.14, p < 0.0001 |
| Injecting Opioid, n, % | 39 (88.6 %) | 27 (61.4 %) | X2(1) = 15.87, p < 0.0001 |
| Benzodiazepines Co-Use, n, % | 14 (31.8 %) | 7 (16.3 %) | X2(1) = 4.45, p = 0.0349 |
| Alcohol Co-Use, n, % | 12 (27.3 %) | 5 (11.4 %) | X2(1) = 12.72, p = 0.0004 |
| Other Drug Co-Use, n, % | 34 (77.3 %) | 30 (68.2 %) | X2(1) = 2.60, p = 0.11 |
| Testing Opioid before Usea, n, % | 13 (29.5 %) | 13 (29.5 %) | X2(1) = 0.13, p = 0.72 |
| Following Abstinence with Same Level of Use, n, % | 12 (27.3 %) | 4 (9.3 %) | X2(1) = 19.47, p < 0.0001 |
| Enrolled in Methadone or Suboxone Treatmenta, n, % | 0 (0.0 %) | 14 (31.8 %) | --b |
| >4 Alcoholic Drinks/Day, n, % | 5 (11.4 %) | 0 (0 %) | --b |
| Total Score (0–14), mean (SD) | 6.2 (2.8) | 2.4 (2.1) | X2(1) = 85.50, p < 0.0001 |
a
Item represents protective factor, rather than risk factor.
b
Analysis could not be conducted due to extreme values.